Tag: Statins
Fewer Adults Eligible for Statins With PREVENT Equations
Most adults eligible for statins based on PREVENT equations did not report statin use
Statin Initiation Cuts Mortality in Older Adults With Chronic Kidney Disease
Findings seen among older adults with stage 3 to 4 disease with no prior atherosclerotic cardiovascular disease
Lipid-Lowering Drugs Save Lives, but Use Decreasing
In 2019 to 2020, 56 percent of patients with high cholesterol were on statins for primary prevention and 85 percent for secondary prevention
Rosuvastatin, Atorvastatin Have Comparable Efficacy for CAD
Comparable efficacy seen for composite outcome; rosuvastatin linked to lower LDL-cholesterol levels
High-Intensity Statins Underused With Atherosclerotic Cardiovascular Disease
Authors say findings show gaps between practice and guideline-based care
Hypertension, Statin Use Increased for Individuals Using TAF for PrEP
Incident hypertension, statin use higher with tenofovir alafenamide fumarate compared with tenofovir disoproxil fumarate
Upfront Combo Lipid-Lowering Therapy Best for Acute Coronary Syndrome
Combination approach better than statin monotherapy for all-cause mortality at one, three, and five years in acute coronary syndromes
Statin Use Linked to Reduced Risk for CRC Incidence, Mortality in Patients With IBD
Benefit for incident CRC was duration-dependent, with significantly reduced risk after two or more years of use
Statin Exposure Not Linked to Increased Risk for Recurrent ICH
Survivors of spontaneous intracerebral hemorrhage with statin exposure have a lower risk for any stroke, ischemic stroke
Drop in LDL Cholesterol Greater With Low-, Moderate-Intensity Statins for Seniors
Initiators of statins aged 75 years or older had higher mean percentage reduction than those younger than 50 years
